Today’s minor market pullback notwithstanding, the broad market remains healthy and strong, and thus I continue to recommend aggressive investment in a diversified portfolio of stocks. Today’s recommendation is an undervalued large-cap in the drug industry that has good growth prospects and a fat dividend to boot.
